Ftse Mib
34.834,30
0,95%
DAX
18.652,67
0,44%
S&P 500
5.352,96
-0,02%
NASDAQ
17.173,12
-0,09%
Bitcoin
70.691,39
-0,10%
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Myriad Genetics Inc (MYGN) Myriad Genetics Inc (MYGN) Notizie

Myriad Genetics Inc

MYGN
22,30
-0,40 (-1,76%)
07 Giu 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
06/6/202422:06EDGAR2Form 8-K - Current report
04/6/202423:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/6/202416:32EDGAR2Form 144 - Report of proposed sale of securities
04/6/202415:00GLOBEMyriad Genetics Launches New Universal Plus Panel for..
03/6/202422:06EDGAR2Form 8-K - Current report
03/6/202422:05GLOBEGenetics in Medicine Publishes Myriad Genetics..
03/6/202419:48EDGAR2Form 144 - Report of proposed sale of securities
30/5/202423:55GLOBEQIAGEN and Myriad Genetics develop distributable homologous..
24/5/202400:00GLOBEMyriad Genetics Showcases New Research and Product..
16/5/202422:05GLOBENew Study Published in JCO Precision Oncology Shows Myriad..
15/5/202423:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/5/202423:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/5/202422:24EDGAR2Form 144 - Report of proposed sale of securities
14/5/202422:26EDGAR2Form 144 - Report of proposed sale of securities
13/5/202422:24EDGAR2Form 144 - Report of proposed sale of securities
13/5/202418:14EDGAR2Form 144 - Report of proposed sale of securities
08/5/202414:23IHMARKETNEWSReddit Rises 15% After First Quarterly Report, Upstart and..
08/5/202414:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/5/202422:05EDGAR2Form 8-K - Current report
07/5/202422:05GLOBEMyriad Genetics Reports Strong First Quarter 2024 Financial..
07/5/202415:00GLOBEMyriad Genetics Announces Reorganization of European..
30/4/202422:05GLOBEMyriad Genetics to Release First Quarter 2024 Financial..
17/4/202414:00GLOBENearly Half of Americans Say They’ve Lost Time in Their..
16/4/202415:15GLOBENew Myriad Genetics Study Published in Prenatal Diagnosis..
09/4/202414:00GLOBEMyriad Genetics Research Shows Reduction in Hospitalizations..
22/3/202402:40GLOBEMyriad Genetics Announces Foundational Patent Granted for..
20/3/202421:05GLOBEMyriad Genetics Announces Patent Granted for SneakPeek® Snap..
04/3/202422:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202414:31EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
27/2/202422:05EDGAR2Form 8-K - Current report
27/2/202422:05GLOBEMyriad Genetics Reports Strong Fourth Quarter and Full-Year..
27/2/202415:15GLOBEMyriad Genetics and National Cancer Center Hospital East in..
26/2/202422:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202422:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202422:05GLOBEMyriad Genetics to Release Fourth Quarter and Full Year 2023..
15/2/202422:05GLOBEMyriad Genetics Appoints Dallas Reed, MD, FACOG, FACMG as..
14/2/202422:47EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202414:24EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/2/202416:14EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
01/2/202415:25GLOBEMyriad Genetics Completes Acquisition of Precise Tumor,..
31/1/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/1/202423:00GLOBEMyriad Genetics Names George Daneker Jr., MD, as President..
29/1/202422:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/1/202422:21EDGAR2Form 3 - Initial statement of beneficial ownership of..
23/1/202422:31EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
22/1/202420:03EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
19/1/202400:10GLOBEMyriad Genetics to Acquire Precise Tumor, Precise Liquid and..
16/1/202415:00EDGAR2Form 8-K - Current report
09/1/202422:05GLOBEMyriad Genetics Applauds New Germline Testing Guideline for..
03/1/202422:05GLOBEMyriad Genetics to Present at 42nd Annual J.P. Morgan..
Apertura: 22,56 Min: 22,26 Max: 23,27
Chiusura: 22,70

La tua Cronologia

NASDAQ
MYGN
Myriad Genetics
BOV
RDNI3
RNI ON
AMEX
TSH
Teche
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network